Literature DB >> 29150003

CRISPR/Cas9 Technology: Applications and Human Disease Modeling.

Marta Martinez-Lage1, Raúl Torres-Ruiz2, Sandra Rodriguez-Perales3.   

Abstract

The CRISPR/Cas9 system development has revolutionized the field of genome engineering through the efficient creation of targeted breaks in the DNA of almost any organism and cell type, opening an avenue for a wide range of applications in biomedical research and medicine. Apart from gene edition through knock-in or knock-out approaches, CRISPR/Cas9 technology has been used for many other purposes, including regulation of endogenous gene expression, epigenome editing, live-cell imaging of chromosomal loci, edition of RNA and high-throughput screening. With all those technological improvements, CRISPR/Cas9 system has broadened the number of alternatives for studying gene function and the generation of more accurate disease models. Although many mechanistic questions remain to be answered and several challenges have yet to be addressed, the use of CRISPR/Cas9-based genome engineering technologies will increase our knowledge of disease processes and their treatment in the near future.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  CRISPR applications; activation; disease model; gene editing; genome engineering; repression

Mesh:

Year:  2017        PMID: 29150003     DOI: 10.1016/bs.pmbts.2017.09.002

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  6 in total

1.  Disease modeling of core pre-mRNA splicing factor haploinsufficiency.

Authors:  Katherine A Wood; Charlie F Rowlands; Wasay Mohiuddin Shaikh Qureshi; Huw B Thomas; Weronika A Buczek; Tracy A Briggs; Simon J Hubbard; Kathryn E Hentges; William G Newman; Raymond T O'Keefe
Journal:  Hum Mol Genet       Date:  2019-11-15       Impact factor: 6.150

2.  CD229 (Ly9) a Novel Biomarker for B-Cell Malignancies and Multiple Myeloma.

Authors:  Giovanna Roncador; Joan Puñet-Ortiz; Lorena Maestre; Luis Gerardo Rodríguez-Lobato; Scherezade Jiménez; Ana Isabel Reyes-García; Álvaro García-González; Juan F García; Miguel Ángel Piris; Santiago Montes-Moreno; Manuel Rodríguez-Justo; Mari-Pau Mena; Carlos Fernández de Larrea; Pablo Engel
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.575

3.  The R229Q mutation of Rag2 does not characterize severe immunodeficiency in mice.

Authors:  Young Jin; Ara Lee; Ja Hyun Oh; Han-Woong Lee; Sang-Jun Ha
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

Review 4.  Narrative review of gene modification: applications in three-dimensional (3D) bioprinting.

Authors:  Bowen Fu; Jianlin Shen; Yu Chen; Yanjiao Wu; Heshi Zhang; Huan Liu; Wenhua Huang
Journal:  Ann Transl Med       Date:  2021-10

Review 5.  Gene editing and its applications in biomedicine.

Authors:  Guanglei Li; Xiangyang Li; Songkuan Zhuang; Liren Wang; Yifan Zhu; Yangcan Chen; Wen Sun; Zeguang Wu; Zhuo Zhou; Jia Chen; Xingxu Huang; Jin Wang; Dali Li; Wei Li; Haoyi Wang; Wensheng Wei
Journal:  Sci China Life Sci       Date:  2022-02-18       Impact factor: 10.372

6.  Generation of corrected hiPSC clones from a Cornelia de Lange Syndrome (CdLS) patient through CRISPR-Cas-based technology.

Authors:  Alessandro Umbach; Giulia Maule; Eyemen Kheir; Alessandro Cutarelli; Marika Foglia; Luca Guarrera; Luca L Fava; Luciano Conti; Enrico Garattini; Mineko Terao; Anna Cereseto
Journal:  Stem Cell Res Ther       Date:  2022-09-02       Impact factor: 8.079

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.